Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening.
Jover R, Herráiz M, Alarcón O, Brullet E, Bujanda L, Bustamante M, Campo R, Carreño R, Castells A, Cubiella J, García-Iglesias P, Hervás AJ, Menchén P, Ono A, Panadés A, Parra-Blanco A, Pellisé M, Ponce M, Quintero E, Reñé JM, Sánchez del Río A, Seoane A, Serradesanferm A, Soriano Izquierdo A, Vázquez Sequeiros E; Spanish Society of Gastroenterology; Spanish Society of Gastrointestinal Endoscopy Working Group. Jover R, et al. Among authors: pellise m. Endoscopy. 2012 Apr;44(4):444-51. doi: 10.1055/s-0032-1306690. Epub 2012 Mar 21. Endoscopy. 2012. PMID: 22438159 Free article. No abstract available.
Incidence and clinical significance of hyperamylasemia after endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of pancreatic lesions: a prospective and controlled study.
Fernández-Esparrach G, Ginès A, García P, Pellisé M, Solé M, Cortés P, Gimeno-García AZ, Sendino O, Navarro S, Llach J, Bordas JM, Castells A. Fernández-Esparrach G, et al. Among authors: pellise m. Endoscopy. 2007 Aug;39(8):720-4. doi: 10.1055/s-2007-966719. Endoscopy. 2007. PMID: 17661248
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.
Gonzalo V, Lozano JJ, Muñoz J, Balaguer F, Pellisé M, Rodríguez de Miguel C, Andreu M, Jover R, Llor X, Giráldez MD, Ocaña T, Serradesanferm A, Alonso-Espinaco V, Jimeno M, Cuatrecasas M, Sendino O, Castellví-Bel S, Castells A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Gonzalo V, et al. Among authors: pellise m. PLoS One. 2010 Jan 19;5(1):e8777. doi: 10.1371/journal.pone.0008777. PLoS One. 2010. PMID: 20098741 Free PMC article.
Colorectal cancer prognosis twenty years later.
Bujanda L, Sarasqueta C, Hijona E, Hijona L, Cosme A, Gil I, Elorza JL, Asensio JI, Larburu S, Enríquez-Navascués JM, Jover R, Balaguer F, Llor X, Bessa X, Andreu M, Paya A, Castells A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Bujanda L, et al. World J Gastroenterol. 2010 Feb 21;16(7):862-7. doi: 10.3748/wjg.v16.i7.862. World J Gastroenterol. 2010. PMID: 20143465 Free PMC article.
EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study.
Fernández-Esparrach G, Ayuso-Colella JR, Sendino O, Pagés M, Cuatrecasas M, Pellisé M, Maurel J, Ayuso-Colella C, González-Suárez B, Llach J, Castells A, Ginès A. Fernández-Esparrach G, et al. Among authors: pellise m. Gastrointest Endosc. 2011 Aug;74(2):347-54. doi: 10.1016/j.gie.2011.03.1257. Gastrointest Endosc. 2011. PMID: 21802588 Clinical Trial.
Susceptibility genetic variants associated with early-onset colorectal cancer.
Giráldez MD, López-Dóriga A, Bujanda L, Abulí A, Bessa X, Fernández-Rozadilla C, Muñoz J, Cuatrecasas M, Jover R, Xicola RM, Llor X, Piqué JM, Carracedo A, Ruiz-Ponte C, Cosme A, Enríquez-Navascués JM, Moreno V, Andreu M, Castells A, Balaguer F, Castellví-Bel S; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Giráldez MD, et al. Carcinogenesis. 2012 Mar;33(3):613-9. doi: 10.1093/carcin/bgs009. Epub 2012 Jan 10. Carcinogenesis. 2012. PMID: 22235025
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.
Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, Lamas MJ, López R, Candamio S, Gallardo E, Paré L, Baiget M, Páez D, López-Fernández LA, Cortejoso L, García MI, Bujanda L, González D, Gonzalo V, Rodrigo L, Reñé JM, Jover R, Brea-Fernández A, Andreu M, Bessa X, Llor X, Xicola R, Palles C, Tomlinson I, Castellví-Bel S, Castells A, Ruiz-Ponte C, Carracedo A; EPICOLON Consortium. Fernandez-Rozadilla C, et al. Pharmacogenomics J. 2013 Jun;13(3):209-17. doi: 10.1038/tpj.2012.2. Epub 2012 Feb 7. Pharmacogenomics J. 2013. PMID: 22310351
[Timing of polyethylene glycol administration is a key factor in the tolerability and efficacy of colon preparation in colorectal cancer screening].
Rodríguez De Miguel C, Serradesanferm A, Del Manzano S, Cárdenas A, Fernández-Esparrach G, Ginés A, Ricart E, Sendino O, González-Suárez B, López-Cerón M, Llach J, Grau J, Castells A, Pellisé M. Rodríguez De Miguel C, et al. Among authors: pellise m. Gastroenterol Hepatol. 2012 Apr;35(4):236-42. doi: 10.1016/j.gastrohep.2012.01.012. Epub 2012 Mar 23. Gastroenterol Hepatol. 2012. PMID: 22445938 Clinical Trial. Spanish.
250 results